AZN.UK

10,782

-1.19%↓

GSK

1,393.5

-0.11%↓

AZN.UK

10,782

-1.19%↓

GSK

1,393.5

-0.11%↓

AZN.UK

10,782

-1.19%↓

GSK

1,393.5

-0.11%↓

AZN.UK

10,782

-1.19%↓

GSK

1,393.5

-0.11%↓

AZN.UK

10,782

-1.19%↓

GSK

1,393.5

-0.11%↓

Search

Indivior PLC

Fechado

1,242 1.47

Visão Geral

Variação de preço das ações

24h

Atual

Mín

1242

Máximo

1242

Indicadores-chave

By Trading Economics

Rendimento

-19M

47M

Vendas

-33M

266M

P/E

Médio do Setor

330

38.156

Margem de lucro

17.669

Funcionários

1,030

EBITDA

-30M

76M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+10.24% upside

Dividendos

By Dow Jones

Próximos Ganhos

31 de jul. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

653M

1.5B

Abertura anterior

1240.53

Fecho anterior

1242

Indivior PLC Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

25 de jul. de 2025, 17:53 UTC

Grandes Movimentos do Mercado

Genworth Shares Rise On UK Court Ruling That Could Lead to $750 Million Windfall

25 de jul. de 2025, 15:58 UTC

Ganhos
Grandes Movimentos do Mercado

Aon Shares Rise After 2Q Earnings Beat

25 de jul. de 2025, 15:08 UTC

Grandes Movimentos do Mercado

AST SpaceMobile Shares Slide After Convertible Notes, Stock Offerings

25 de jul. de 2025, 21:40 UTC

Conversa de Mercado

Starbucks' Spending Hikes Are Misdirected -- Market Talk

25 de jul. de 2025, 21:23 UTC

Conversa de Mercado

Honeywell's Growth Seen Holding Up Despite Recent Headwinds -- Market Talk

25 de jul. de 2025, 20:40 UTC

Ganhos

Tesla Stock Is Rising. Robo-taxi Trumps a Lack of New Models. -- Barrons.com

25 de jul. de 2025, 20:10 UTC

Ganhos

These Stocks Moved the Most Today: Intel, Centene, Charter, Newmont, Deckers, Boston Beer, Tesla, and More -- Barrons.com

25 de jul. de 2025, 19:56 UTC

Ganhos

Correction to Why Bargain Hunters Are Flocking to 'Bin Stores' -- Barrons.com on July 20

25 de jul. de 2025, 19:14 UTC

Conversa de Mercado

Oil Futures Post Back-to-Back Weekly Losses -- Market Talk

25 de jul. de 2025, 19:10 UTC

Conversa de Mercado

U.S. Natural Gas Futures Appear to Stabilize -- Market Talk

25 de jul. de 2025, 19:01 UTC

Ganhos

These Stocks Are Moving the Most Today: Intel, Centene, Charter, Newmont, Deckers, Boston Beer, Tesla, and More -- Barrons.com

25 de jul. de 2025, 18:45 UTC

Conversa de Mercado

Gold Ends Down Week on Lower Note -- Market Talk

25 de jul. de 2025, 18:35 UTC

Aquisições, Fusões, Aquisições de Empresas

Sale Could Fetch Around $1B, Sources Say -- WSJ

25 de jul. de 2025, 18:35 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH in Talks to Sell Marc Jacobs -- WSJ

25 de jul. de 2025, 18:35 UTC

Aquisições, Fusões, Aquisições de Empresas

Suitors for Marc Jacobs Include Authentic, Bluestar Alliance and WHP Global, Sources Say -- WSJ

25 de jul. de 2025, 18:35 UTC

Aquisições, Fusões, Aquisições de Empresas

LVMH Exploring Sale of Fashion Brand Marc Jacobs, Sources Say -- WSJ

25 de jul. de 2025, 17:38 UTC

Grandes Movimentos do Mercado

Genworth Shares Rise On UK Court Ruling That Could Lead to $750M Windfall

25 de jul. de 2025, 17:26 UTC

Conversa de Mercado

U.S. Oil Rig Count Extends Decline -- Market Talk

25 de jul. de 2025, 17:13 UTC

Ganhos

Tesla Stock Is Rising. Robo-taxi Trumps a Lack of New Models. -- Barrons.com

25 de jul. de 2025, 16:46 UTC

Ganhos

Volkswagen Teases Made-in-America Audis, Porsches After $1.5 Billion Tariff Hit -- 2nd Update

25 de jul. de 2025, 16:45 UTC

Ganhos

Apple Earnings Are Next Week. Why This Analyst Says Be Cautious. -- Barrons.com

25 de jul. de 2025, 16:27 UTC

Ganhos

These Stocks Are Moving the Most Today: Intel, Centene, Charter, Newmont, Deckers, Boston Beer, Tesla, and More -- Barrons.com

25 de jul. de 2025, 16:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

25 de jul. de 2025, 16:02 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Berkshire Stock Is Losing Its Buffett Premium. Now Is the Time to Buy. -- Barrons.com

25 de jul. de 2025, 15:34 UTC

Ganhos

Intel's Harsh Reality Nullifies Tariff Boost -- WSJ

25 de jul. de 2025, 15:06 UTC

Conversa de Mercado

Base Metal Prices Fall on Stronger U.S. Dollar -- Market Talk

25 de jul. de 2025, 15:05 UTC

Ganhos

These Stocks Are Moving the Most Today: Intel, Centene, Charter, Newmont, Deckers, Boston Beer, Comfort Systems, and More -- Barrons.com

25 de jul. de 2025, 14:45 UTC

Conversa de Mercado

Oil Rangebound Amid U.S.-EU Trade Uncertainty -- Market Talk

25 de jul. de 2025, 14:44 UTC

Conversa de Mercado

Gold Futures Set to End Week Lower on Easing Trade War Concerns -- Market Talk

25 de jul. de 2025, 14:36 UTC

Conversa de Mercado
Ganhos

Phillips 66 CEO Says California Administration Supports of LA Plant Closure -- Market Talk

Comparação entre Pares

Variação de preço

Indivior PLC Previsão

Preço-alvo

By TipRanks

10.24% parte superior

Previsão para 12 meses

Média 1,364.8 GBX  10.24%

Máximo 1,637.758 GBX

Mínimo 967.766 GBX

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Indivior PLC - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

4 ratings

4

Comprar

0

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Indivior PLC

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose. Its core marketed products include SUBLOCADE and SUBUTEX PRO buprenorphine extended-release monthly injections; SUBOXONE, a buprenorphine and naloxone sublingual film; SUBOXONE, a buprenorphine and naloxone sublingual tablet; and SUBUTEX, a buprenorphine sublingual tablet for the treatment of opioid use disorder. The company also offers OPVEE nasal spray for opioid overdose reversal; and PERSERIS extended-release injectable suspension for the treatment of schizophrenia in adults. In addition, it is developing INDV-2000, a selective orexin-1 receptor antagonist that completed phase 1 clinical trial for the treatment of opioid use disorder (OUD); INDV-1000, a selective GABAb positive allosteric modulator, which is in pre-clinical development phase for the treatment of alcohol use disorder in collaboration with ADDEX therapeutics; INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc.; and CT-102, a digital therapeutic for the treatment of OUD in collaboration with Click Therapeutics. Further, the company is developing INDV-5004, a drinabant injection to treat acute cannabinoid overdose. It has a strategic partnership with Aelis Farma to develop AEF0117, a synthetic CB1 specific signaling inhibitor that is in phase 2B clinical trial for the treatment of cannabis use disorder. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.